Next generation TKIs offer several therapeutic advantages: - Improved Selectivity: They are more selective for cancer cells, which minimizes damage to normal cells and reduces side effects. - Enhanced Potency: These TKIs are more potent, allowing for lower doses and reducing toxicity. - Broad Spectrum: They can target multiple mutations and cancer types, increasing their applicability.
